Tricida

Layoffs
Biotech

Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave

The four biotechs outlined plans to lay off staff in response to financial headaches and stuttering drug development pipelines.
Nick Paul Taylor Nov 15, 2022 6:45am
layoffs job cuts fired exit restructuring layoff reduction

Rubius lays off 82% of staff while Tricida seeks a sale

Nov 3, 2022 9:30am
Kidney

Phase 3 fail seals fate of Tricida's FDA-rejected kidney drug

Oct 24, 2022 9:50am
FDA Building 2

Tricida sinks as FDA rejection raises prospect of new trial

Aug 25, 2020 8:20am
Nasdaq

Tricida files for $150M IPO to fund kidney disease drug approval

Jun 5, 2018 9:20am
Money

Tricida raises $55M, to get kidney disease data this year

Jul 25, 2016 8:44am